BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Jan. 28, 2004
View Archived Issues
Dendreon Pulls In $130.7M In Public Offering For Provenge
In the second biotech public offering of the year, Dendreon Corp. raised $130.7 million, money that will be used to fund clinical trials and develop a commercial infrastructure for Provenge. (BioWorld Today)
Read More
SuperGen Completes Orathecin Pancreatic Cancer Rolling NDA
Read More
Sirna Agrees To RNAi Cancer Drug Collaboration With Lilly
Read More
Cellegesic Hits Primary Endpoint; Cellegy Expects Summer Filing
Read More
Other News To Note
Read More
Appointments And Advancements
Read More